In Vitro Assessment of the Biologic Activity of Interferon Beta Formulations used for the Treatment of Relapsing Multiple Sclerosis

By            

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 288-299

Taylor & Francis Ltd

Access to resources Recommend Favorite

Delayed Occurrence of a Severe Cutaneous Reaction in a Multiple Sclerosis Patient Taking Interferon Beta-1b

By Cohen Bruce A.   Greenberger Paul A.   Saini Sunil  

Allergy and Asthma Proceedings, Vol. 19, Iss. 2, 1998-03 ,pp. : 85-88

OceanSide Publications, Inc

Access to resources Recommend Favorite

Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta

By Bergh F.T.   Dayyani F.   Ziegler-Heitbrock L.  

Journal of Neuroimmunology, Vol. 146, Iss. 1, 2004-01 ,pp. : 176-188

Elsevier

Access to resources Recommend Favorite

Multiple sclerosis-like disease secondary to alpha interferon

By Matsuo Toshihiko   Takabatake Ryu  

Ocular Immunology and Inflammation, Vol. 10, Iss. 4, 2002-12 ,pp. : 299-304

Informa Healthcare

Access to resources Recommend Favorite

Correlation Between Interferon Production and Clinical Disease Activity in Patients with Multiple Sclerosis

By Dettke M.   Scheidt P.   Prange H.   Kirchner H.  

Journal of Clinical Immunology, Vol. 17, Iss. 4, 1997-07 ,pp. : 293-300

Springer Publishing Company

Access to resources Recommend Favorite